NGS-based RNA-seq Market Future Trends and Industry insight to 2022

The global NGS-based RNA-seq market is projected to reach USD 2.65 billion by 2022 from USD 1.05 billion in 2017, at a CAGR of 20.2%. Factors such as the advantages of RNA-seq over micro array technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.

Click Here for Complete Report on NGS-based RNA-seq Market spread across 153 Pages, Profiling 12 Companies and Supported with 42 Tables and 45 Figures at        http://www.rnrmarketresearch.com/ngs-based-rna-seq-market-by-products-services-sample-preparation-consumables-bioinformatics-technology-sbs-smrt-application-de-novo-transcriptome-epigenetics-small-rna-end-user-research-centers-bio-st-to-2022-market-report.html .

In 2016, the sequencing platforms and consumables segment is expected to account for the largest share of the market. The data analysis, storage, and management is expected to register the highest growth rate owing to its development of more efficient data analysis solutions and growing computational capabilities of data analytics providers.

Introduction

1 Objectives of the Study

2 Market Definition

3 Market Scope

4 Currency

5 Limitations

6 Stakeholders

Geographically, the NGS-based RNA-seq market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe and Asia-Pasific. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022, owing to focus on R&D activities and the low cost of NGS products & services in this region.

Click Here for Sample Papers of NGS-based RNA-seq Market with Top Trends and Company Profile at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1024407 .

The global NGS-based RNA-seq market is highly competitive, with a large number of global and local players. In 2016, the market was dominated by Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.). Product launches, agreements, and partnerships were the major strategies adopted by market players to achieve growth in the market

Premium Insights

1 NGS-based RNA-seq Market Overview

2 Market Growth Rate, By Technology, 2017 vs 2022 (USD Million)

3 Market, By Application and Region, 2017 (USD Million)

4 Market, By End User, 2017 vs 2022

5 Geographical Snapshot of the Market

This report studies the NGS-based RNA-seq market based on product & service, application, technology, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.

Click Now for More Details on “NGS-based RNA-seq Market by Products & Services (Sample Preparation, Consumables, Bioinformatics), Technology (SBS, SMRT), Application (De novo, Transcriptome Epigenetics, Small RNA), End User (Research Centers, BioPharma Companies) – Global Forecast to 2022” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1024407 .

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

Contact:

[email protected]  / Call +1 888 391 5441

For further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.